跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
AVSARTAN HCT 300/25 irbesartan 300 mg and hydrochlorothiazide 25 mg tablets blister pack
Approved
STANDARD
AVSARTAN HCT 300/25 irbesartan 300 mg and hydrochlorothiazide 25 mg tablets blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
5df958f736c6ec09
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
5df958f736c6ec09
Product Name
AVSARTAN HCT 300/25 irbesartan 300 mg and hydrochlorothiazide 25 mg tablets blister pack
Artg Id
272662
Artg Name
AVSARTAN HCT 300/25 irbesartan 300 mg and hydrochlorothiazide 25 mg tablets blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2017-03-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/08bfeb9326c46873a0b13faac325a9bf.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/8bf213f133148f29a03a53045a58bea7.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
5df958f736c6ec09
Type
Standard
Back to TGA Approvals
AVSARTAN HCT 300/25 irbesartan 300 mg and hydrochlorothiazide 25 mg tablets blister pack - TGA Drug Approval Details